M Peter Marinkovich

5PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Property law (excl. intellectual property law)Epigenetics (incl. genome methylation and epigenomics)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2024
Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation.

Mårten C G Winge, Mazen Nasrallah, Leandra V Jackrazi

|Dec 14, 2022
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.

Shireen V Guide, Mercedes E Gonzalez, I Sinem Bağcı

|Oct 17, 2022
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.

Jodi Y So, Jaron Nazaroff, Chinonso V Iwummadu

|Mar 29, 2022
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.

Irina Gurevich, Pooja Agarwal, PeiPei Zhang

Pageof 1